We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK laid out proposed changes to bring needed sunlight to clinical trials in a policy report released by recently appointed Under Secretary of State for Health, Nicola Blackwood. Read More
As pressure continues to build on drugmakers to address high drug prices, Eli Lilly announced that it will market a half-priced generic of its Humalog insulin injection in the U.S. Read More
Novartis filed a lawsuit on Friday accusing Janssen of falsely claiming that its plaque psoriasis drug Tremfya (guselkumab) is superior to Novartis’ product, Cosentyx (secukinumab). Read More
The FDA required a clinical trial among rheumatoid arthritis patients to test the risk of heart problems, cancer and opportunistic infections. Read More
One committee member voted “no” on the delay, saying “we do patients some potential benefit here if this agent is used constructively and intelligently while we wait for additional data.” Read More
The scheme involved fraudulent claims submissions to Medicare Part D plan sponsors for drugs that the pharmacy never ordered or dispensed to beneficiaries. Read More
A class action lawsuit filed in California claims Genentech took advantage of cancer patients by packaging oncology drugs in oversized vials. Read More
Several pharma industry trade groups and drugmakers wrote to the FDA to endorse a Pfizer petition asking the agency to take more aggressive steps against biosimilar-related misinformation. Read More